What’s Vulnerable › Vulnerabilities

CVE-2015-3965

• Severity: high (CVSS 8.8 v3.0)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 2.9% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2019-03-23 · updated 2026-06-17
• Weakness: CWE-264

Description

Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.

Affected products

• Hospira Symbiq Infusion System: through 3.13

References

• https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01
• https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01

Get alerted when CVE-2015-3965 or the next vulnerability affects your stack